| Literature DB >> 29608407 |
Shinji Yamada1, Mika K Kaneko1, Shunsuke Itai1,2, Yao-Wen Chang1, Takuro Nakamura1, Miyuki Yanaka1, Satoshi Ogasawara3, Takeshi Murata3, Hiroaki Uchida4, Hideaki Tahara4, Hiroyuki Harada2, Yukinari Kato1,5.
Abstract
Podoplanin (PDPN), a type I transmembrane sialoglycoprotein, is expressed on normal renal podocytes, pulmonary type I alveolar cells, and lymphatic endothelial cells. Increased expression of PDPN in cancers is associated with poor prognosis and hematogenous metastasis through interactions with C-type lectin-like receptor 2 (CLEC-2) on platelets. We previously reported a novel PMab-48 antibody, which is an anti-dog PDPN (dPDPN) monoclonal antibody (mAb) recognizing PDPN expressed in lymphatic endothelial cells. However, the binding epitope of PMab-48 is yet to be clarified. In this study, an enzyme-linked immunosorbent assay and flow cytometry were used to investigate epitopes of PMab-48. The results revealed that the critical epitope of PMab-48 comprises Asp29, Asp30, Ile31, Ile32, and Pro33 of dPDPN.Entities:
Keywords: dPDPN; dog podoplanin; epitope mapping; monoclonal antibody
Mesh:
Substances:
Year: 2018 PMID: 29608407 DOI: 10.1089/mab.2018.0006
Source DB: PubMed Journal: Monoclon Antib Immunodiagn Immunother ISSN: 2167-9436